logo

Esperion Therapeutics (ESPR)



Trade ESPR now with
  Date
  Headline
12/14/2017 4:39:10 PM Esperion Appoints Jeffrey Berkowitz To Board Of Directors
11/7/2017 3:36:17 PM Jefferies Is Increasing Esperion Therapeutics (ESPR) FY18 Estimate To -8.54 From -9.36
11/7/2017 3:35:58 PM Jefferies Is Increasing Esperion Therapeutics (ESPR) FY17 Estimate To -7.43 From -7.45
8/9/2017 9:30:37 PM Esperion Therapeutics Prices Public Offering Of 3.10 Mln Shares At $49.00/shr
8/8/2017 7:36:54 AM Esperion Reports Positive Top-Line Results From Phase 2 Study Of Bempedoic Acid / Ezetimibe Plus Atorvastatin
3/20/2017 7:36:37 AM Esperion Says FDA Confirmed Regarding Regulatory Pathway To Approval For An LDL-C Lowering Indication For Bempedoic Acid